ZA989885B - Use of macrolides for the treatment of cancer and macular degeneration - Google Patents
Use of macrolides for the treatment of cancer and macular degenerationInfo
- Publication number
- ZA989885B ZA989885B ZA989885A ZA989885A ZA989885B ZA 989885 B ZA989885 B ZA 989885B ZA 989885 A ZA989885 A ZA 989885A ZA 989885 A ZA989885 A ZA 989885A ZA 989885 B ZA989885 B ZA 989885B
- Authority
- ZA
- South Africa
- Prior art keywords
- macrolides
- cancer
- treatment
- macular degeneration
- macular
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96147397A | 1997-10-31 | 1997-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA989885B true ZA989885B (en) | 1999-05-05 |
Family
ID=25504514
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA989885A ZA989885B (en) | 1997-10-31 | 1998-10-29 | Use of macrolides for the treatment of cancer and macular degeneration |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1027060A2 (en) |
| JP (1) | JP2001521891A (en) |
| KR (1) | KR20010031577A (en) |
| CN (1) | CN1278178A (en) |
| AR (1) | AR043071A1 (en) |
| AU (1) | AU1206799A (en) |
| BG (1) | BG104436A (en) |
| BR (1) | BR9813318A (en) |
| CA (1) | CA2307850A1 (en) |
| HU (1) | HUP0100012A3 (en) |
| IL (1) | IL135518A0 (en) |
| NO (1) | NO20002189L (en) |
| PL (1) | PL340604A1 (en) |
| SK (1) | SK6172000A3 (en) |
| TR (1) | TR200001147T2 (en) |
| WO (1) | WO1999022722A2 (en) |
| ZA (1) | ZA989885B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK1278881T3 (en) | 2000-04-13 | 2010-05-10 | Biotica Tech Ltd | Glycosylated hybrid products and their preparation and use |
| AU2003272471B2 (en) | 2002-09-18 | 2010-10-07 | Trustees Of The University Of Pennsylvania | Method of inhibiting choroidal neovascularization |
| TW200420573A (en) | 2002-09-26 | 2004-10-16 | Rib X Pharmaceuticals Inc | Bifunctional heterocyclic compounds and methods of making and using same |
| US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| JP4928937B2 (en) | 2003-03-28 | 2012-05-09 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Migrastatin analogs and uses thereof |
| US7083802B2 (en) | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
| US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
| US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
| CN108101948A (en) * | 2004-02-27 | 2018-06-01 | 瑞伯-X医药品有限公司 | Macrocyclic compound and its making and use method |
| JP5383037B2 (en) * | 2004-02-27 | 2014-01-08 | リブ−エックス ファーマシューティカルズ，インコーポレイテッド | Macrocyclic compounds and methods of making and using them |
| JP5149001B2 (en) | 2004-05-25 | 2013-02-20 | スローン−ケッタリング・インスティテュート・フォー・キャンサー・リサーチ | Migrastatin analogues in the treatment of cancer |
| WO2006034478A2 (en) | 2004-09-23 | 2006-03-30 | Sloan-Kettering Institute For Cancer Research | Isomigrastatin analogs in the treatment of cancer |
| US8637070B2 (en) | 2005-02-09 | 2014-01-28 | Santen Pharmaceutical Co., Ltd. | Rapamycin formulations and methods of their use |
| PL1904056T3 (en) | 2005-07-18 | 2009-09-30 | Minu Llc | Use of a macrolide to restore corneal sensation |
| US8470985B2 (en) | 2005-08-24 | 2013-06-25 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| US8278281B2 (en) | 2005-08-24 | 2012-10-02 | Rib-X Pharmaceuticals, Inc. | Triazole compounds and methods of making and using the same |
| EP2001438A2 (en) | 2006-02-09 | 2008-12-17 | Macusight, Inc. | Stable formulations, and methods of their preparation and use |
| ES2563288T3 (en) | 2006-03-23 | 2016-03-14 | Santen Pharmaceutical Co., Ltd | Rapamycin in low doses for the treatment of diseases related to vascular permeability |
| CN106317146B (en) * | 2015-06-18 | 2019-06-21 | 沈阳药科大学 | Bicyclic clarithomycin derivative and its as tumour cell increment inhibitor purposes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6461090A (en) * | 1989-10-30 | 1991-05-02 | Abbott Laboratories | Injectable formulation for lipophilic drugs |
| US5498424A (en) * | 1994-11-30 | 1996-03-12 | Klein; Ira | Method of treating obesity |
-
1998
- 1998-10-29 ZA ZA989885A patent/ZA989885B/en unknown
- 1998-10-29 AR ARP980105434A patent/AR043071A1/en unknown
- 1998-10-30 KR KR1020007004625A patent/KR20010031577A/en not_active Application Discontinuation
- 1998-10-30 IL IL13551898A patent/IL135518A0/en unknown
- 1998-10-30 TR TR2000/01147T patent/TR200001147T2/en unknown
- 1998-10-30 AU AU12067/99A patent/AU1206799A/en not_active Abandoned
- 1998-10-30 PL PL98340604A patent/PL340604A1/en unknown
- 1998-10-30 BR BR9813318-7A patent/BR9813318A/en not_active Application Discontinuation
- 1998-10-30 SK SK617-2000A patent/SK6172000A3/en unknown
- 1998-10-30 EP EP98955206A patent/EP1027060A2/en not_active Withdrawn
- 1998-10-30 CA CA002307850A patent/CA2307850A1/en not_active Abandoned
- 1998-10-30 CN CN98810825A patent/CN1278178A/en active Pending
- 1998-10-30 HU HU0100012A patent/HUP0100012A3/en unknown
- 1998-10-30 WO PCT/US1998/023043 patent/WO1999022722A2/en not_active Application Discontinuation
- 1998-10-30 JP JP2000518656A patent/JP2001521891A/en not_active Withdrawn
-
2000
- 2000-04-27 NO NO20002189A patent/NO20002189L/en unknown
- 2000-05-15 BG BG104436A patent/BG104436A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20002189L (en) | 2000-06-28 |
| TR200001147T2 (en) | 2000-08-21 |
| HUP0100012A3 (en) | 2003-07-28 |
| EP1027060A2 (en) | 2000-08-16 |
| JP2001521891A (en) | 2001-11-13 |
| WO1999022722A2 (en) | 1999-05-14 |
| CA2307850A1 (en) | 1999-05-14 |
| PL340604A1 (en) | 2001-02-12 |
| SK6172000A3 (en) | 2001-03-12 |
| BR9813318A (en) | 2000-08-22 |
| AU1206799A (en) | 1999-05-24 |
| NO20002189D0 (en) | 2000-04-27 |
| BG104436A (en) | 2000-12-29 |
| KR20010031577A (en) | 2001-04-16 |
| HUP0100012A2 (en) | 2001-05-28 |
| IL135518A0 (en) | 2001-05-20 |
| AR043071A1 (en) | 2005-07-20 |
| CN1278178A (en) | 2000-12-27 |
| WO1999022722A3 (en) | 1999-08-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0104081A3 (en) | Device for the treatment of macular degeneration | |
| ZA989885B (en) | Use of macrolides for the treatment of cancer and macular degeneration | |
| ZA979096B (en) | Viral and cancer treatment | |
| ZA957483B (en) | Compounds and methods for the treatment of cancer | |
| AU2072201A (en) | Agents and methods for the treatment of proliferative diseases | |
| AU2212299A (en) | Compositions and methods for the treatment of tumor | |
| HUP0102473A3 (en) | Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases | |
| IL127739A0 (en) | Retinoyloxy (substituted) alkylene butyrates useful for the treatment of cancer and other proliferative diseases | |
| AU2476200A (en) | Ribozyme therapy for the treatment and/or prevention of restenosis | |
| GB9811598D0 (en) | Diagnosis and treatment of cancer | |
| IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
| AU8068198A (en) | Methods for treating human cancers | |
| IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| GB9819999D0 (en) | Treatment of cancer | |
| ZA984650B (en) | Intratumoral administration of triphenylethylenes for the treatment of cancer | |
| EP1023076A4 (en) | Use of the p-ten suppressor gene in diagnosis and treatment of cancer | |
| GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
| AU6288698A (en) | Apparatus for stimulating the human body | |
| AU6404698A (en) | Treatment methods for obtaining therapeutic products and resulting products | |
| AU4406899A (en) | Progesterone treatment of cancer | |
| AU3205295A (en) | Antisense oligonucleotides and methods for the treatment of schistosomiasis | |
| ZA988293B (en) | Compositions and methods for the treatment of tumor. | |
| GB9703517D0 (en) | Steroid treatment | |
| AUPO955497A0 (en) | Treatment of cancer |